Trust Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $75.5K | Sell |
208
-182
| -47% | -$62.3K | 0.01% | 252 |
|
|
2026
Q1 | $137K | Buy |
390
+3
| +0.8% | +$1.07K | 0.01% | 204 |
|
|
2025
Q4 | $127K | Buy |
387
+182
| +89% | +$57.7K | 0.01% | 207 |
|
|
2025
Q3 | $57.9K | Hold |
205
| – | – | 0.01% | 210 |
|
|
2025
Q2 | $57.2K | Hold |
205
| – | – | 0.01% | 215 |
|
|
2025
Q1 | $63.9K | Hold |
205
| – | – | 0.01% | 211 |
|
|
2024
Q4 | $53.4K | Buy |
205
+170
| +486% | +$50.4K | 0.01% | 220 |
|
|
2024
Q3 | $11.3K | Hold |
35
| – | – | ﹤0.01% | 291 |
|
|
2024
Q2 | $10.9K | Hold |
35
| – | – | ﹤0.01% | 283 |
|
|
2024
Q1 | $9.95K | Hold |
35
| – | – | ﹤0.01% | 288 |
|
|
2023
Q4 | $10.1K | Hold |
35
| – | – | ﹤0.01% | 265 |
|
|
2023
Q3 | $9.41K | Sell |
35
-3
| -8% | -$749 | ﹤0.01% | 268 |
|
|
2023
Q2 | $8.44K | Hold |
38
| – | – | ﹤0.01% | 275 |
|
|
2023
Q1 | $9.19K | Hold |
38
| – | – | ﹤0.01% | 262 |
|
|
2022
Q4 | $10K | Sell |
38
-56
| -60% | -$15K | ﹤0.01% | 253 |
|
|
2022
Q3 | $21K | Hold |
94
| – | – | ﹤0.01% | 224 |
|
|
2022
Q2 | $23K | Hold |
94
| – | – | 0.01% | 231 |
|
|
2022
Q1 | $23K | Sell |
94
-86
| -48% | -$19.8K | ﹤0.01% | 242 |
|
|
2021
Q4 | $40K | Hold |
180
| – | – | 0.01% | 189 |
|
|
2021
Q3 | $38K | Sell |
180
-114
| -39% | -$26.2K | 0.01% | 186 |
|
|
2021
Q2 | $72K | Sell |
294
-1,940
| -87% | -$477K | 0.05% | 147 |
|
|
2021
Q1 | $556K | Sell |
2,234
-74
| -3% | -$17.7K | 0.4% | 63 |
|
|
2020
Q4 | $531K | Sell |
2,308
-101
| -4% | -$23.3K | 0.42% | 65 |
|
|
2020
Q3 | $612K | Sell |
2,409
-1,860
| -44% | -$461K | 0.51% | 59 |
|
|
2020
Q2 | $1.01M | Buy |
4,269
+415
| +11% | +$94.7K | 0.96% | 30 |
|
|
2020
Q1 | $781K | Sell |
3,854
-254
| -6% | -$55.5K | 0.86% | 34 |
|
|
2019
Q4 | $990K | Sell |
4,108
-47
| -1% | -$10.4K | 0.87% | 36 |
|
|
2019
Q3 | $804K | Sell |
4,155
-1,091
| -21% | -$209K | 0.76% | 40 |
|
|
2019
Q2 | $967K | Sell |
5,246
-14,530
| -73% | -$2.6M | 0.89% | 39 |
|
|
2019
Q1 | $3.76M | Sell |
19,776
-5,459
| -22% | -$1.04M | 2.19% | 10 |
|
|
2018
Q4 | $4.91M | Sell |
25,235
-7,627
| -23% | -$1.49M | 2.73% | 10 |
|
|
2018
Q3 | $6.81M | Buy |
32,862
+1,030
| +3% | +$203K | 3.07% | 13 |
|
|
2018
Q2 | $5.88M | Buy |
31,832
+3,261
| +11% | +$577K | 2.69% | 14 |
|
|
2018
Q1 | $4.87M | Buy |
28,571
+28,421
| +18,947% | +$5.22M | 1.8% | 17 |
|
|
2017
Q4 | $26K | Hold |
150
| – | – | 0.01% | 204 |
|
|
2017
Q3 | $28K | Hold |
150
| – | – | 0.02% | 176 |
|
|
2017
Q2 | $26K | Sell |
150
-233
| -61% | -$37.9K | 0.01% | 198 |
|
|
2017
Q1 | $63K | Buy |
383
+58
| +18% | +$9.64K | 0.03% | 163 |
|
|
2016
Q4 | $48K | Sell |
325
-15,105
| -98% | -$2.27M | 0.02% | 174 |
|
|
2016
Q3 | $2.57M | Buy |
15,430
+14,455
| +1,483% | +$2.44M | 1.13% | 32 |
|
|
2016
Q2 | $148K | Hold |
975
| – | – | 0.06% | 119 |
|
|
2016
Q1 | $146K | Buy |
975
+500
| +105% | +$74.3K | 0.07% | 119 |
|
|
2015
Q4 | $77.1K | Hold |
475
| – | – | 0.04% | 141 |
|
|
2015
Q3 | $66K | Hold |
475
| – | – | 0.04% | 150 |
|
|
2015
Q2 | $73K | Buy |
475
+325
| +217% | +$52.1K | 0.05% | 163 |
|
|
2015
Q1 | $24K | Buy |
+150
| New | +$23.6K | 0.02% | 192 |
|
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Trust Company's AMGN Position: Q2 2026 in Review
Trust Company reduced its Amgen (AMGN) stake by 47% in Q2 2026, selling an estimated $62.3K and leaving 208 shares worth $75.5K. The position accounts for 0.01% of the portfolio, ranked #252.
Trust Company first reported a position in AMGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $6.81M in Q3 2018. 664 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Trust Company held 208 shares of Amgen worth $75.5K as of Q2 2026.
- Trust Company sold 182 Amgen shares in Q2 2026, an estimated $62.3K.
- Amgen made up 0.01% of Trust Company's portfolio in Q2 2026, its #252 holding.
- Trust Company first reported a position in Amgen in Q1 2015 and has held it in 46 quarters since.
- Trust Company's Amgen position peaked at $6.81M in Q3 2018.
- 664 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.